These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 22576567)
21. Prevention of Asthma Exacerbation in a Mouse Model by Simultaneous Inhibition of NF-κB and STAT6 Activation Using a Chimeric Decoy Strategy. Miyake T; Miyake T; Sakaguchi M; Nankai H; Nakazawa T; Morishita R Mol Ther Nucleic Acids; 2018 Mar; 10():159-169. PubMed ID: 29499930 [TBL] [Abstract][Full Text] [Related]
22. Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells. Tomita N; Morishita R; Tomita S; Yamamoto K; Aoki M; Matsushita H; Hayashi S; Higaki J; Ogihara T J Hypertens; 1998 Jul; 16(7):993-1000. PubMed ID: 9794740 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor kappaB and ets transcription factors. Nakashima H; Aoki M; Miyake T; Kawasaki T; Iwai M; Jo N; Oishi M; Kataoka K; Ohgi S; Ogihara T; Kaneda Y; Morishita R Circulation; 2004 Jan; 109(1):132-8. PubMed ID: 14662712 [TBL] [Abstract][Full Text] [Related]
25. A therapeutic effect of STAT6 decoy oligodeoxynucleotide ointment in atopic dermatitis: a pilot study in adults. Igawa K; Satoh T; Yokozeki H Br J Dermatol; 2009 May; 160(5):1124-6. PubMed ID: 19292714 [No Abstract] [Full Text] [Related]
26. [Effects of nuclear factor of kappa B decoy oligodeoxynucleotides on murine with multiple myeloma]. Shi KH; Jiang HL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):132-6. PubMed ID: 25687060 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model. Miwa K; Nakashima H; Aoki M; Miyake T; Kawasaki T; Iwai M; Oishi M; Kataoka K; Ohgi S; Ogihara T; Kaneda Y; Morishita R Gene Ther; 2005 Jul; 12(14):1109-18. PubMed ID: 15800662 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB. Tomita N; Morishita R; Tomita S; Kaneda Y; Higaki J; Ogihara T; Horiuchi M Exp Nephrol; 2001; 9(3):181-90. PubMed ID: 11340302 [TBL] [Abstract][Full Text] [Related]
31. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. Yagi R; Nagai H; Iigo Y; Akimoto T; Arai T; Kubo M J Immunol; 2002 Feb; 168(4):2020-7. PubMed ID: 11823539 [TBL] [Abstract][Full Text] [Related]
32. [Influence of nuclear factor-kappaB decoy transfection on nuclear factor-kappaB activity and vascular endothelial growth factor/urokinase-type plasminogen activator/intercellular cell adhesion molecule-1 level of SKOV3 cells]. Lu JP; Sun H; Cao CC; Ou ZL Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):533-7. PubMed ID: 15363352 [TBL] [Abstract][Full Text] [Related]
33. The immunostimulatory effect of CpG oligodeoxynucleotides on peripheral blood mononuclear cells of healthy dogs and dogs with atopic dermatitis. Jassies-van der Lee A; Rutten V; Spiering R; van Kooten P; Willemse T; Broere F Vet J; 2014 Apr; 200(1):103-8. PubMed ID: 24461202 [TBL] [Abstract][Full Text] [Related]
34. A molecular mechanism for IL-4 suppression of loricrin transcription in epidermal keratinocytes: implication for atopic dermatitis pathogenesis. Bao L; Mohan GC; Alexander JB; Doo C; Shen K; Bao J; Chan LS Innate Immun; 2017 Nov; 23(8):641-647. PubMed ID: 28952836 [TBL] [Abstract][Full Text] [Related]
35. Transcription factors as molecular targets: molecular mechanisms of decoy ODN and their design. Tomita N; Ogihara T; Morishita R Curr Drug Targets; 2003 Nov; 4(8):603-8. PubMed ID: 14577649 [TBL] [Abstract][Full Text] [Related]
36. Suppression of skin lesions by transdermal application of CpG-oligodeoxynucleotides in NC/Nga mice, a model of human atopic dermatitis. Inoue J; Aramaki Y J Immunol; 2007 Jan; 178(1):584-91. PubMed ID: 17182599 [TBL] [Abstract][Full Text] [Related]
37. Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model. Miyake T; Aoki M; Nakashima H; Kawasaki T; Oishi M; Kataoka K; Tanemoto K; Ogihara T; Kaneda Y; Morishita R Gene Ther; 2006 Apr; 13(8):695-704. PubMed ID: 16397509 [TBL] [Abstract][Full Text] [Related]
38. Crocin Ameliorates Atopic Dermatitis Symptoms by down Regulation of Th2 Response via Blocking of NF-κB/STAT6 Signaling Pathways in Mice. Sung YY; Kim HK Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400140 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice. Zhang X; Zhang J; Wang L; Wei H; Tian Z BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579 [TBL] [Abstract][Full Text] [Related]
40. Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. Matsushita H; Morishita R; Nata T; Aoki M; Nakagami H; Taniyama Y; Yamamoto K; Higaki J; Yasufumi K; Ogihara T Circ Res; 2000 May; 86(9):974-81. PubMed ID: 10807870 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]